Loading viewer...
investor_presentation
Format: PDF investor_presentation
COMPANY ADMINISTRATION from Dimerix (ASX)
Dimerix Phase 3 Trial Last Patient Receives First Dose
presentation
investor_presentation
24 Pages
Soligenix, Inc.
Iovance Biotherapeutics Investor Presentation — November 2021
investor_presentationinvestor_presentation
50 Pages
Iovance Biotherapeutics, Inc